Tue.Sep 19, 2023

article thumbnail

COVID-19 ICU Admissions, Deaths Associated With Old Age and Multimorbidity

Drug Topics

The presence of 4 or more comorbidities was strongly associated with a higher risk of critical outcomes, regardless of vaccination status.

Vaccines 219
article thumbnail

HHS Recommends Cannabis Move From Schedule 1 to Schedule 3, the Result Will Impact Opportunities for Drug Research

Pharmacy Times

Moving cannabis to Schedule 3 will make it easier to research, resulting in the development and creation of new cannabinoid-based pharmaceuticals, with notable potential in oncology.

164
164
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

OTC Products, Oral Prescriptions Demonstrate Efficacy in Episodic Migraine

Drug Topics

Although there were some differences in response after dosing, both OTC and oral prescriptions demonstrated statistically significant improvements in pain.

200
200
article thumbnail

Study: Shared Decision-Making in Cardiovascular Health is Infrequently Utilized, Despite Benefits

Pharmacy Times

Shared decision-making can be better incorporated into cardiovascular care guidelines by including decision aids, such as informational flyers or online tools to help patients.

145
145
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Mobile Apps for Medication Management

Drug Topics

Pharmacists and patients can utilize mobile apps to help manage medications.

200
200
article thumbnail

IVIG Therapy Shows Insignificant Benefit to Reducing Mortality, Length of Hospitalization in Patients with COVID-19

Pharmacy Times

The analysis results showed no statistically significant impact on either outcome, but results from prior prospective studies suggest that intravenous immunoglobulin may lengthen hospital stay for patients with severe COVID-19.

Hospitals 145

More Trending

article thumbnail

Oracle Health integrates generative AI, voice tech into EHR system to automate medical note-taking

Fierce Healthcare

Software giant Oracle has integrated generative AI services into its Cerner electronic medical record system as health IT companies race to harness this cutting-edge tech for providers. | Software giant Oracle has integrated generative AI services into its Cerner EHR system as health tech companies race to harness this cutting-edge tech for providers.

Cerner 143
article thumbnail

STAT+: Artificial wombs, after years in development, reach FDA review for human trials

STAT

The artificial womb, a device aiming to save infants born way too soon, is inching closer to being tested in humans. The technology is close enough to reality that the Food and Drug Administration has decided to convene a two-day panel starting Tuesday to discuss how to best evaluate safety and effectiveness, as well as the ethical quandaries in running clinical trials.

FDA 145
article thumbnail

Phase 3 Trial Reinforces Favorability of Roflumilast Cream 0.05% for Atopic Dermatitis in Children

Pharmacy Times

A supplemental New Drug Application will be submitted for roflumilast cream 0.05% for the treatment of mild to moderate atopic dermatitis in children 2 to 5 years of age.

132
132
article thumbnail

Opinion: A popular breast cancer genomic test underestimates risks for Black women

STAT

When a woman first learns she has breast cancer, her mind immediately floods with “what now?” questions as she grapples with how this disease will impact her life. Unfortunately, Black women also have to ask themselves, “Will my racial heritage and ethnicity affect the care I receive and chances of survival?

144
144
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

First Interchangeable Biosimilar to Insulin Found Noninferior Insulin Glargine for Diabetes

Pharmacy Times

Insulin glargine-yfgn is more affordable than the reference product and patients do not require prescriber authorization switch.

149
149
article thumbnail

STAT+: After a high-profile pressure campaign, Cepheid agrees to sell a TB test at cost

STAT

Following a high-profile pressure campaign, the company that makes a crucial tuberculosis test has agreed to sell its product at cost to an international organization that works with low-income countries to eradicate infectious diseases. But the move was met with mixed reactions by advocates who say prices should drop for still other tests. Danaher will now sell its GeneXpert test cartridge for $7.97 each to the Global Fund to Fight AIDS, Tuberculosis, and Malaria, as well as to some less-develo

137
137
article thumbnail

Inside the FDA's Form 483 findings at Novo Nordisk's North Carolina semaglutide plant

Fierce Pharma

Novo Nordisk’s shares continued to trend downward Tuesday after reports surfaced that the FDA had recently flagged manufacturing shortfalls at the Danish drugmaker’s Clayton, North Carolina product | After inspecting Novo’s Clayton, North Carolina, facility between July 6 and July 13, 2023, the FDA officially chided the company for a pair of quality control lapses, according to a Form 483 seen by Fierce Pharma.

FDA 131
article thumbnail

STAT+: Biotech lab-space demand falls sharply as industry’s ‘sugar high’ turns into a ‘reset’

STAT

Demand for new lab space has plummeted by more than half since the end of 2021, and life science vacancy rates are the highest they’ve been in a decade amid the biotech industry’s ongoing downturn, according to a report released Tuesday by Jones Lang LaSalle, a commercial real estate services company Tenant demand, measured by the total amount of new space that companies are looking to lease, dropped from 25.3 million square feet at the end of 2021 to 10.1 million square feet by th

133
133
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Clinical Overview: Potentially Harmful Medications in Heart Failure

Pharmacy Times

An average patient with heart failure can take up to 6 medications for guideline-directed medical therapy; however, they may have other comorbidities that require pharmacologic management.

123
123
article thumbnail

Rep. Adam Smith weighs in on the country’s mental health crisis with his own story

STAT

WASHINGTON — Rep. Adam Smith (D-Wash.) knew when he hit rock bottom. “I woke up one morning in early April of 2016 and seriously considered the possibility that I might never be able to get out of bed,” he opens his recent memoir, “Lost and Broken,” which details the six years in which “crippling anxiety” and chronic pain dominated his life even as he bounced back and forth from the Capitol to northern Seattle, the district he has represented for

127
127
article thumbnail

Moderna Announces Expansion of mRNA Research Across Respiratory, Oncology, Rare Disease Franchises

Pharmacy Times

Moderna has advanced 6 programs into late-stage development, including for respiratory conditions, latent and other viruses, oncology, and rare diseases.

132
132
article thumbnail

Industry Voices—Medicare’s assault on home health keeps patients from going home

Fierce Healthcare

A home health agency in Missouri recently announced it is shutting down due to the impact of | Home healthcare providers are experiencing severe payment cuts along with challenges to retain nurses and therapists, putting healthcare services at home in jeopardy.

128
128
article thumbnail

Walgreens, Global Healthy Living Foundation to host free virtual health event

Drug Store News

In the “Making the Most of Your Vaccines” virtual event, experts will discuss the role pharmacists, nutrition, exercise and mindfulness can play in one’s vaccination experience.

Vaccines 126
article thumbnail

Equip nabs additional investment to expand virtual eating disorder treatment services to adult patients

Fierce Healthcare

Digital health startup Equip is expanding its virtual eating disorder treatment services to adults as demand for care continues to grow. | Equip banked an additional investment from General Catalyst to fuel its growth as it expands its virtual eating disorder therapy services to adults.

128
128
article thumbnail

STAT+: FDA weighs animal data, ethical dilemmas at panel on artificial wombs

STAT

The Food and Drug Administration’s advisory panel of pediatric experts met on Tuesday to discuss advances in artificial womb technology, which aim to save the lives of premature babies. The goal of the meeting was to discuss measures for evaluating the safety and efficacy of an artificial womb. The group grappled with the limits of current animal data, as well as the ethical difficulties in running human trials.

FDA 124
article thumbnail

Elevance Health's CarelonRx launches new drug discount program

Fierce Healthcare

Elevance Health's pharmacy benefit manager, CarelonRx, is launching a new program that aims to make it easier for members to access drug discounts at the pharmacy counter. | Elevance Health's pharmacy benefit manager, CarelonRx, is launching a new program that aims to make it easier for members to access drug discounts at the pharmacy counter.

126
126
article thumbnail

ACIP Updates Flu Vaccine Recommendations

Drug Topics

Standout updates include a relaxed recommendation for patients with a history of egg allergies, and that all available influenza vaccines for the 2023 to 2023 flu season are quadrivalent.

article thumbnail

Hospitals' online and over-the-phone cash prices rarely align, study finds

Fierce Healthcare

Patients checking their local hospital’s website for the cost of medical services may not find the same prices as those who called on the phone, according to a newly published study. | The comparison of 60 hospitals' listed prices and those obtained by secret shopper callers "highlight the continued challenges for uninsured patients and others who attempt to comparison shop for healthcare," researchers wrote.

Hospitals 124
article thumbnail

STAT+: Pear’s shadow effect: Data from a Medicaid digital health experiment does the policy rounds

STAT

Pear Therapeutics may be gone, but one of its most important deals is still driving critical conversations about how medical apps can find a foothold in the slow-moving health care system. In recent months, representatives of the Massachusetts state Medicaid program, MassHealth, have been presenting data suggesting reSET and reSET-O, Pear’s prescription apps that treat substance use disorder and opioid use disorder, saved the state money over a one-year period from 2021 to 2022.

FDA 120
article thumbnail

Behavioral health system's illegal sober home kickbacks endangered vulnerable patients, DOJ alleges

Fierce Healthcare

A Massachusetts behavioral health system allegedly pushed thousands of substance abuse patients to choose its services by illegally offering free sober housing at facilities it knew to be unsafe, a | Federal and state law enforcement officials allege that Massachusetts-based Bournewood Health Systems illegally induced thousands of patients to partner sober homes it knew were dangerous, allowing the behavioral health provider to bill government programs for millions.

124
124
article thumbnail

After TIGIT divorce, Novartis returns tislelizumab to BeiGene as PD-1 gains first European nod

Fierce Pharma

Novartis has ended its major cancer immunotherapy collaboration with BeiGene more than two years after touting the benefits of having a PD-1 inhibitor. | Novartis has ended its major cancer immunotherapy collaboration with BeiGene more than two years after touting the benefits of having a PD-1 inhibitor.

118
118
article thumbnail

CMS rule to increase Medicare Savings Program enrollment

Fierce Healthcare

The Centers for Medicare & Medicaid Services (CMS) finalized a rule Monday to streamline enrollment in Medicare Savings Programs (MSPs) with the aim of making coverage affordable for 860,000 mo | A $26.16 billion CMS rule will streamline Medicare Savings Program enrollment, reducing administrative burden in the process.

118
118
article thumbnail

The 2023 PharmaVoice 100

PharmaVoice

This year’s honorees are influential and devoted leaders lifting the pillars of the industry to new heights.

145
145
article thumbnail

Astellas touts 2-year trial of geographic atrophy drug Izervay but shares few details

Fierce Pharma

Gaining FDA approval last month for its geographic atro | Astellas reported results of a phase 3 trial that assessed Izervay’s effectiveness and safety over a 24-month period. While the company said that the study met its primary objective of reducing the rate of geographic atrophy growth compared to a sham therapy, it offered little else about the results.

FDA 115
article thumbnail

It’s Time to Gear Up for Fall Vaccines

Pharmacy Times

Pharmacists play a vital role in providing education and administering influenza, COVID-19, and RSV Vaccines

Vaccines 139
article thumbnail

Novo Nordisk taps Aspen to help produce insulin for Africa

Fierce Pharma

Novo Nordisk, following a similar move by its diabetes rival Eli Lilly, is teaming up with Aspen Pharmacare to shore up insulin supplies in Africa, which currently imports more than 80% of its medi | Novo Nordisk is teaming up with Aspen Pharmacare to shore up insulin supplies in Africa, which currently imports more than 80% of its medicine.

113
113
article thumbnail

Pharma Award Finalists for CPHI Barcelona Have Been Announced

BioPharm

The finalists for this year’s CPHI Barcelona Pharma Awards span 12 categories with awards ranging from accelerating innovations through to improved sustainability and best start-up initiative.

111
111
article thumbnail

Biopharma’s AI revolution is about more than algorithms

Fierce Pharma

Artificial intelligence (AI) has enormous potential in healthcare, but all too often, it gets misunderstood. Especially with the proliferation of AI in other industries and chatGPT. | With the right infrastructure, intelligent tools stand to not only process data but also improve clinical decision-making—helping find more patients for biopharma companies, and faster, too.

112
112